In summary, our findings indicated that METTL3‐mediated m6A modification of LNCAROD enhanced its stability in a YTHDC1‐dependent manner, which caused the upregulation of LNCAROD expression levels in ESCC cells. Here, METTL3 is linked to esophageal squamous cell carcinoma.